CTRI/2019/02/017812尚未招募3 期
Safety and Efficacy of treatment regimen consisting of Rifampicin (600 mg), Moxifloxacin (400mg) and Minocycline (100 mg)-once a month supervisory dose to be given to leprosy patients ( 6 months to PB, 12 months to MB ) and comparing it with standard WHO regimen currently being given. - NI
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •New untreated leprosy case
排除标准
- •Any patient condition (Pregnancy, Lactation, Co-infection TB,Diebetes, Hypertension, Peripheral Vascular Diseases, Choronic Artery Diseses) that would be expected to confound with patients monitoring would not be included in the study. Patients who present with reaction or disability needing steroid would also not be included
研究者
相似试验
招募中
2 期
Efficacy and safety study of a therapeutic regimen using Tamibarotene (Am80) and arsenic trioxide (ATO) in combination with Gemtuzumab Ozogamicin (GO) as a post-remission therapy for relapsed acute promyelocytic leukemia (APL)Relapsed acute promyelocytic leukemiaRelapsed acure promyelocytic leukemia, Tamibarotene, Arsenic trioxide, Gemtuzumab ozogamicinJPRN-jRCTs041190101Kiguchi Toru39
进行中（未招募）
1 期
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 18.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001815-38-DEAllergan Limited750
进行中（未招募）
1 期
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown LinesFacial Rhytides (Forehead Lines, Glabellar Lines)MedDRA version: 18.1Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001860-36-IEAllergan Limited400
进行中（未招募）
1 期
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 17.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001815-38-BEAllergan Limited750
进行中（未招募）
1 期
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)MedDRA version: 18.0Level: LLTClassification code 10048043Term: WrinklingSystem Organ Class: 100000004858EUCTR2014-001815-38-GBAllergan Limited750